UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status

The Journal of steroid biochemistry and molecular biology, 2009-10, Vol.117 (1), p.31-41

2009

Volltextzugriff (PDF)

Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking

Journal of endocrinology, 1999-08, Vol.162 (2), p.265-270

1999

Volltextzugriff (PDF)

P17 Letrozole (2.5 mg o.d.) is superior to anastrozole (1.0 mg o.d.) concerning suppression of both plasma and tissue estrogen levels in postmenopausal breast cancer patients

Breast (Edinburgh), 2007, Vol.16, p.S17-S17

2007

Volltextzugriff (PDF)

229 Effects of CYP2C19 genotype on tamoxifen and estrogen metabolism

European journal of cancer supplements, 2010, Vol.8 (5), p.60-60

2010

Volltextzugriff (PDF)

A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors

The Journal of steroid biochemistry and molecular biology, 1995-12, Vol.55 (3), p.409-412

1995

Volltextzugriff (PDF)

The insulin-like growth factor system in human immunodeficiency virus infection : Relations to immunological parameters, disease progression, and antiretroviral therapy

The journal of clinical endocrinology and metabolism, 2001, Vol.86 (1), p.227-233

2001

Volltextzugriff (PDF)

Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate

Journal of steroid biochemistry and molecular biology, 1997-04, Vol.61 (3), p.255-260

1997

Volltextzugriff (PDF)

Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients

Clinical endocrinology (Oxford), 1995, Vol.42 (1), p.23-30

1995

Volltextzugriff (PDF)

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients

The Journal of steroid biochemistry and molecular biology, 1995-05, Vol.52 (5), p.491-496

1995

Volltextzugriff (PDF)

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency

European journal of cancer (1990), 1999-07, Vol.35 (7), p.1070-1075

1999

Volltextzugriff (PDF)

Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients

The Journal of steroid biochemistry and molecular biology, 1995-11, Vol.55 (2), p.193-195

1995

Volltextzugriff (PDF)

Letrozole (Femara) causes potent suppression of breast cancer tissue estrogen levels in the neoadjuvant setting

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10532-10532

2006

Volltextzugriff (PDF)

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

The Journal of steroid biochemistry and molecular biology, 2005-09, Vol.96 (5), p.415-422

2005

Volltextzugriff (PDF)

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

The Journal of steroid biochemistry and molecular biology, 2002-05, Vol.81 (1), p.95-102

2002

Volltextzugriff (PDF)

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment

Breast cancer research and treatment, 1992-01, Vol.23 (1-2), p.57-62

1992

Volltextzugriff (PDF)

Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition

Journal of Steroid Biochemistry, 1989-10, Vol.33 (4), p.541-545

1989

Volltextzugriff (PDF)

Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects

Breast cancer research and treatment, 1986, Vol.7 Suppl, p.S77-S82

1986

Volltextzugriff (PDF)

The Insulin-Like Growth Factor System in Human Immunodeficiency Virus Infection: Relations to Immunological Parameters, Disease Progression, and Antiretroviral Therapy 1

The journal of clinical endocrinology and metabolism, 2001-01, Vol.86 (1), p.227-233

2001

Volltextzugriff (PDF)

The Insulin-Like Growth Factor System in Human Immunodeficiency Virus Infection: Relations to Immunological Parameters, Disease Progression, and Antiretroviral Therapy1

The journal of clinical endocrinology and metabolism, 2001-01, Vol.86 (1), p.227-233

2001

Volltextzugriff (PDF)

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer

Breast cancer research and treatment, 1996-01, Vol.39 (3), p.335-341

1996

Volltextzugriff (PDF)

Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients

The Journal of steroid biochemistry and molecular biology, 1997-09, Vol.63 (1), p.53-58

1997

Volltextzugriff (PDF)

Influence of treatment with onapristone on the IGF-system in breast cancer patients

The Journal of steroid biochemistry and molecular biology, 1998-08, Vol.66 (3), p.159-163

1998

Volltextzugriff (PDF)

Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients

Cancer chemotherapy and pharmacology, 1998, Vol.42 (1), p.46-52

1998

Volltextzugriff (PDF)

Adenosine instead of supranormal potassium in cardioplegic solution preserves endothelium-derived hyperpolarization factor-dependent vasodilation

European journal of cardio-thoracic surgery, 2008-01, Vol.33 (1), p.18-24

2008

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status

Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking

P17 Letrozole (2.5 mg o.d.) is superior to anastrozole (1.0 mg o.d.) concerning suppression of both plasma and tissue estrogen levels in postmenopausal breast cancer patients

229 Effects of CYP2C19 genotype on tamoxifen and estrogen metabolism

A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors

The insulin-like growth factor system in human immunodeficiency virus infection : Relations to immunological parameters, disease progression, and antiretroviral therapy

Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate

Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency

Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients

Letrozole (Femara) causes potent suppression of breast cancer tissue estrogen levels in the neoadjuvant setting

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment

Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition

Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects

The Insulin-Like Growth Factor System in Human Immunodeficiency Virus Infection: Relations to Immunological Parameters, Disease Progression, and Antiretroviral Therapy 1

The Insulin-Like Growth Factor System in Human Immunodeficiency Virus Infection: Relations to Immunological Parameters, Disease Progression, and Antiretroviral Therapy1

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer

Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients

Influence of treatment with onapristone on the IGF-system in breast cancer patients

Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients

Adenosine instead of supranormal potassium in cardioplegic solution preserves endothelium-derived hyperpolarization factor-dependent vasodilation

Suchergebnisse filtern